¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2023³âµµ ´ëÇѺñ´¢ÀÇÇÐȸ ÅëÇÕÇмú´ëȸ(KUCE 2023) (1ÀÏÂ÷) : 2023-04-14

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

2023³âµµ ´ëÇѺñ´¢ÀÇÇÐȸ ÅëÇÕÇмú´ëȸ(KUCE 2023) (1ÀÏÂ÷) : 2023-04-14
±³À°ÀÏÀÚ : 2023-04-14
±³À°Àå¼Ò : DCC Á¦2ȸÀÇÀå

±³À°ÁÖÁ¦ : 2023³âµµ ´ëÇѺñ´¢ÀÇÇÐȸ ÅëÇÕÇмú´ëȸ(KUCE 2023) (1ÀÏÂ÷)

ÁÖÃÖ±â°ü : ´ëÇѺñ´¢ÀÇÇÐȸ(19.2 ¸íĪº¯°æ ´ëÇѺñ´¢±â°úÇÐȸ)
´ã´çÀÚ : À̼¼Èñ
¿¬¶ôó : 02-573-8190  

À̸ÞÀÏ : urology@urology.or.kr

±³À°Á¾·ù : ºñ´¢ÀÇÇаú

Âü¼®¿¹»óÀοø : 500¸í
Èñ¸ÁÆòÁ¡ : 4Á¡

Áö¿ª : ´ëÀü±¤¿ª½Ã
±³À°½Ã°£ : 4 ½Ã°£ 0ºÐ

¼¼ºÎ¼ö°­·á : 110,000¿ø  

ºñ°í »çÀüµî·Ï Á¤È¸¿ø: 88,000¿ø ±ºÀÇ°ü/°øº¸ÀÇ: 44,000¿ø Àü°øÀÇ: 33,000¿ø ±¹Á¦È¸¿ø: 88,000¿ø °£È£»ç/¿¬±¸¿ø: 38,500¿ø Á¦¾àȸ»ç ¹× ÀÇ·á±âȸ»ç Á÷¿ø/±âŸ: 110,000¿ø


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 04-14 Á¦2ȸÀÇÀå(103+104) 13:00~13:20 ÃֽŠÀÇ·áÀΰøÁö´É ¿¬±¸µ¿Çâ ¹× ÀÓ»óÀÇÀÇ ¿ªÇÒ Á¤¼º¹®(°æºÏÀÇ´ë ÀÇ·áÁ¤º¸Çб³½Ç)

±³À°½Ã°£ 04-14 Á¦2ȸÀÇÀå(103+104) 13:20~13:40 ÀÇ·áÀΰøÁö´É ¿¬±¸¸¦ À§ÇÑ Áغñ ¹× ÀýÂ÷ Ã߹μö(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 04-14 Á¦2ȸÀÇÀå(103+104) 13:40~14:00 ÀǷ῵»ó ±â¹ÝÀÇ ÀΰøÁö´É ¿¬±¸ ±è¿µ°ï(¼­¿ïÀÇ´ë À¶ÇÕÀÇÇаú)

±³À°½Ã°£ 04-14 Á¦2ȸÀÇÀå(103+104) 14:00~14:20 ºñ´¢±â ¿µ¿ª¿¡¼­ ÀΰøÁö´ÉÀÇ Àû¿ë»ç·Ê ±èÀÀÈñ(¶óÀÌÇÁ½Ã¸Çƽ½º)

±³À°½Ã°£ 04-14 Á¦2ȸÀÇÀå(103+104) 14:30~14:50 The role of I-O agents in non-metastatic urothelial carcinoma ÀÓ¹üÁø(¿ï»êÀÇ´ë)

±³À°½Ã°£ 04-14 Á¦2ȸÀÇÀå(103+104) 14:50~15:10 Peri-operative immunotherapy in high-risk, non-metastatic RCC Á¶Á¤±â(ÇѾçÀÇ´ë)

±³À°½Ã°£ 04-14 Á¦2ȸÀÇÀå(103+104) 15:10~15:30 Management of I-O drug related complications in urologic cancer: sharing basic knowledge ÇÔ¿ø½Ä(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 04-14 Á¦2ȸÀÇÀå(103+104) 15:30~15:50 Management of I-O drug related complications in urologic cancer: sharing real clinical practice ±èÁÂÈÆ(°í·ÁÀÇ´ë Á¾¾ç³»°ú)

±³À°½Ã°£ 04-14 Á¦2ȸÀÇÀå(103+104) 16:10~16:30 Management of low testosterone in prostate cancer survivors ½ÅÀ¯¼·(ÀüºÏÀÇ´ë)

±³À°½Ã°£ 04-14 Á¦2ȸÀÇÀå(103+104) 16:30~16:50 Effects of COVID-19 on male sexual health ¾È¼øÅÂ(°í·ÁÀÇ´ë)

±³À°½Ã°£ 04-14 Á¦2ȸÀÇÀå(103+104) 16:50~17:10 Does Low intensity shockwave therapy have a role for urological diseases other than ED? ±è°­¼·(°¡Å縯ÀÇ´ë)

±³À°½Ã°£ 04-14 Á¦2ȸÀÇÀå(103+104) 17:10~17:30 Office-based management of premature ejaculation ÃÖ¿ì¼®(°Ç±¹ÀÇ´ë)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2023³âµµ ´ëÇѺñ´¢ÀÇÇÐȸ ÅëÇÕÇмú´ëȸ(KUCE 2023) (1ÀÏÂ÷) : 2023-04-14""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û Á¦73Â÷ ´ëÇѼҾÆû¼Ò³â°úÇÐȸ Ãá°èÇмú´ëȸ : 2023-04-14
´ÙÀ½±Û 2023 ´ëÇÑÇ×±Õ¿ä¹ýÇÐȸ ´ëÇÑ°¨¿°ÇÐȸ Ãá°è Çмú´ëȸ : 2023-04-13
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
32 ¼­¿ï [Á¦27±â ÀÇ·áÁ¤Ã¥ÃÖ°íÀ§°úÁ¤] ÀÇ·á±â°ü °¨¿°°ü¸®ÀÇ ¿øÄ¢ " 2018-08-09 0 466 2018-07-28
31 ¼­¿ï ¼­¿ï¾Æ»êº´¿ø 7th AP VALVES 2018 : 2018-08-09 0 714 2018-07-28
30 ¼­¿ï 2018 ´ëÇÑÇ÷¾×ÇÐȸ ºÐ±âÁý´ãȸ : 2018-08-09 0 779 2018-07-28
29 ¼­¿ï Çѱ¹¿ªÇÐȸ ÀÇÇк¸°ÇÇп¡¼­ÀÇ ¿ªÇÐÀû »ç°í¿Í Åë°èÀÇ ÀÀ¿ë 1 : 2018-08-09 0 929 2018-07-28
28 ºÎ»ê ¿ÂÁ¾ÇÕº´¿ø °£¾ÏÁø·áÁöħ : 2018-08-09 0 1,514 2018-07-28
27 °æºÏ ´ëÇÑ ¼Ò¾Æ¾Ë·¹¸£±â È£Èí±âÇÐȸ ´ë±¸°æºÏÁöȸ Áý´ãȸ : 2018-08-07 0 886 2018-07-28
26 ¼­¿ï ´ëÇÑ¿µ»óÀÇÇÐȸ »ó±ÙÀÇ»ç À¯¹æÃÔ¿µ¿ëÀåÄ¡ Ç°Áú°ü¸® ±³À° 3ÀÏÂ÷(8¿ù5ÀÏ) : 2018-08-05 0 662 2018-07-28
25 ¼­¿ï Çѱ¹Á¤½ÅÄ¡·áÇÐȸ Á¤½ÅÄ¡·á Áõ·Ê¹ßÇ¥ : 2018-08-04 0 1,922 2018-07-28
24 ¼­¿ï °¡Å縯´ëÇб³¼­¿ï¼º¸ðº´¿ø 2018 8th Seoul St. Mary's Hospital Spine Center Symposium - Celebration of the Retirement of Professor Kee-Yong Ha : 2018-08-04 0 694 2018-07-28
23 ¼­¿ï 2018³â ´ëÇѺҾÈÀÇÇÐȸ ½ÉÃþ±³À°°úÁ¤ 2ȸ±â : 2018-08-04 0 432 2018-07-28
22 ¼­¿ï ¼­¿ï¾Æ»êº´¿ø 9th Asan-Kumamoto International Joint Symposium : 2018-08-04 0 573 2018-07-28
21 ¼­¿ï 2018³â ½ÅÁ¾ ¹× »ý¹°Å×·¯°¨¿°º´ ´ëÀÀÀü¹®¿ä¿ø ±³À°[»çÀüµî·Ï Çʼö] : 2018-08-03 0 508 2018-07-28
20 ¼­¿ï Á߾Ӵ뺴¿ø »êºÎÀΰú žÆÃÊÀ½ÆÄ ¿¬¼Ó°­Á : 2018-08-02 0 637 2018-07-28
19 ¼­¿ï 2018³â ½ÅÁ¾ ¹× »ý¹°Å×·¯°¨¿°º´ ´ëÀÀÀü¹®¿ä¿ø ±³À°[»çÀüµî·Ï Çʼö] : 2018-08-02 0 410 2018-07-28
18 Ãæ³² 2018 Ãæû³²µµ °øÁߺ¸°ÇÀÇ»ç Á÷¹«±³À° : 2018-08-02 0 622 2018-07-28
1411 | 1412 | 1413 | 1414 | 1415
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷